MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

  1. Monk, B.J.
  2. Grisham, R.N.
  3. Banerjee, S.
  4. Kalbacher, E.
  5. Mirza, M.R.
  6. Romero, I.
  7. Vuylsteke, P.
  8. Coleman, R.L.
  9. Hilpert, F.
  10. Oza, A.M.
  11. Westermann, A.
  12. Oehler, M.K.
  13. Pignata, S.
  14. Aghajanian, C.
  15. Colombo, N.
  16. Drill, E.
  17. Cibula, D.
  18. Moore, K.N.
  19. Christy-Bittel, J.
  20. del Campo, J.M.
  21. Berger, R.
  22. Marth, C.
  23. Sehouli, J.
  24. O’Malley, D.M.
  25. Churruca, C.
  26. Boyd, A.P.
  27. Kristensen, G.
  28. Clamp, A.
  29. Ray-Coquard, I.
  30. Vergote, I.
  31. Montrer des auteurs +
Revue:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Année de publication: 2020

Volumen: 38

Número: 32

Pages: 3753-3762

Type: Article

DOI: 10.1200/JCO.20.01164 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus